ATE469352T1 - Specific monoclonal antibody against terbinafine - Google Patents
Specific monoclonal antibody against terbinafineInfo
- Publication number
- ATE469352T1 ATE469352T1 AT01907523T AT01907523T ATE469352T1 AT E469352 T1 ATE469352 T1 AT E469352T1 AT 01907523 T AT01907523 T AT 01907523T AT 01907523 T AT01907523 T AT 01907523T AT E469352 T1 ATE469352 T1 AT E469352T1
- Authority
- AT
- Austria
- Prior art keywords
- terbinafine
- antibodies
- recovering
- antibody
- monoclonal antibody
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/643—Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0003360.5A GB0003360D0 (en) | 2000-02-14 | 2000-02-14 | Monoclonal antibodies |
| PCT/EP2001/001535 WO2001059458A1 (en) | 2000-02-14 | 2001-02-12 | Specific monoclonal antibody against terbinafine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE469352T1 true ATE469352T1 (de) | 2010-06-15 |
Family
ID=9885556
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01907523T ATE469352T1 (de) | 2000-02-14 | 2001-02-12 | Specific monoclonal antibody against terbinafine |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7122184B2 (de) |
| EP (1) | EP1261874B1 (de) |
| JP (1) | JP3973424B2 (de) |
| AT (1) | ATE469352T1 (de) |
| AU (1) | AU3546701A (de) |
| DE (1) | DE60142225D1 (de) |
| GB (1) | GB0003360D0 (de) |
| WO (1) | WO2001059458A1 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200821276A (en) * | 2006-08-18 | 2008-05-16 | Leo Pharma As | Substituted acetylenic compounds useful for the treatment of diseases |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2526423B1 (fr) | 1982-05-07 | 1987-07-10 | Sandoz Sa | Nouvelles amines insaturees, leur preparation et leur utilisation comme medicaments |
| US5169773A (en) * | 1984-10-04 | 1992-12-08 | Sandoz Ltd. | Monoclonal antibodies to cyclosporins |
| GB9111611D0 (en) | 1991-05-30 | 1991-07-24 | Sandoz Ltd | Liposomes |
| IT1261776B (it) | 1993-03-12 | 1996-06-03 | Mendes Srl | Uso di terbinafina per il trattamento terapeutico della pneumocistosi. |
| IL109159A (en) | 1993-03-29 | 2003-11-23 | Isk Biotech Corp | Immunoassays for tetrachloroiso-phthalonitrile and its metabolites and antibodies for use therein |
| NZ280065A (en) * | 1995-09-20 | 1998-04-27 | Apotex Inc | Preparation of n-alkyl-n-(1-naphthylmethyl)alk-2-en-4-ynylamine derivatives |
| IT1284076B1 (it) * | 1996-06-27 | 1998-05-08 | Dox Al Italia Spa | Frammenti f(ab')2 e relative immunoglobuline igg, attivi come anticorpi specifici verso farmaci e i loro metaboliti, e loro |
-
2000
- 2000-02-14 GB GBGB0003360.5A patent/GB0003360D0/en not_active Ceased
-
2001
- 2001-02-12 US US10/203,076 patent/US7122184B2/en not_active Expired - Fee Related
- 2001-02-12 AT AT01907523T patent/ATE469352T1/de not_active IP Right Cessation
- 2001-02-12 JP JP2001558737A patent/JP3973424B2/ja not_active Expired - Fee Related
- 2001-02-12 WO PCT/EP2001/001535 patent/WO2001059458A1/en not_active Ceased
- 2001-02-12 EP EP01907523A patent/EP1261874B1/de not_active Expired - Lifetime
- 2001-02-12 AU AU35467/01A patent/AU3546701A/en not_active Abandoned
- 2001-02-12 DE DE60142225T patent/DE60142225D1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| GB0003360D0 (en) | 2000-04-05 |
| JP3973424B2 (ja) | 2007-09-12 |
| WO2001059458A1 (en) | 2001-08-16 |
| JP2003522537A (ja) | 2003-07-29 |
| DE60142225D1 (en) | 2010-07-08 |
| AU3546701A (en) | 2001-08-20 |
| US20030087323A1 (en) | 2003-05-08 |
| EP1261874B1 (de) | 2010-05-26 |
| US7122184B2 (en) | 2006-10-17 |
| EP1261874A1 (de) | 2002-12-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES3014740T3 (en) | Treatment of cancer | |
| NO20021992D0 (no) | Anti-prostatastamcelleantigen(PSCA)-antistoffpreparat og fremgangsmåter for anvendelse | |
| IL172982A0 (en) | Antibodies and ca6 antigen specific cytotoxic conjugates and pharmaceutical compositions containing the same | |
| BRPI0613382A8 (pt) | anticorpos isolados, anticorpo monoclonal, célula de hibridoma, método de identificação, método de inibição do crescimento de uma célula, método de tratamento terapêutico, método de determinação da presença de uma proteína, métodos de diagnósticos da presença de tumor | |
| MX2010005966A (es) | Conjugados de anticuerpo monoclonal-molecula asociada dirigidos a la proteina tirosina-cinasa 7 (ptk7). | |
| BR0307216A (pt) | Anticorpos monoclonais humanos para antìgeno de membrana especìfica de próstata (psma) | |
| YU61601A (sh) | Kit i postupak za radioobeležavanje antitela i postupak za odredjivanje imunoreaktivnosti radioobeleženih antitela ćelijskim vezivanjem | |
| LU91616I2 (fr) | Anticorps monoclonal hybride rat-souris(IgG2) soustoutes les formes couvertes par le brevet de base (REMOVAB - Catumaxomab) | |
| AR059809A1 (es) | Anticuerpos anti-5t4 y sus usos | |
| IL186948A0 (en) | Monoclonal antibodies and methods for their use in the detection of cervical disease | |
| EP1841793A4 (de) | Ovr110-antikörperzusammensetzungen und verwendungsverfahren dafür | |
| ES2214722T3 (es) | Metodo de ensayo de peptidos de colageno. | |
| UA108349C2 (uk) | Гуманізоване антитіло з протипухлинною активністю | |
| DE50011181D1 (de) | Nachweis des pyruvatkinase-isoenzyms im stuhl | |
| ATE469352T1 (de) | Specific monoclonal antibody against terbinafine | |
| Jang et al. | Analysis of T cell reactivities to phosphorylcholine‐conjugated hen egg lysozyme in C57BL/6 mice: hapten‐conjugate specificity reflects an altered expression of a major carrier epitope | |
| CN202814982U (zh) | 林可霉素残留快速检测试纸条 | |
| DE602005015855D1 (de) | Verfahren zur herstellung von immunogenen konjugaten | |
| JPH1175839A (ja) | モノクローナル抗体、細胞株及びｎ１，ｎ１２−ジアセチルスペルミンの測定法 | |
| TR200100651T2 (tr) | İki işlevli antikorlar ve bunların tümör-önleyici amilleri hedeflemede kullanımı | |
| ZA202402857B (en) | Antibodies binding cldn18.2 and uses thereof | |
| WO2026010982A2 (en) | Compositions and methods for binding src | |
| JPH06504424A (ja) | モノクローナル抗ＩｇＭ抗体、その生産と使用、およびそれらを生産するためのハイブリドーマ | |
| SG156619A1 (en) | Novel cancer associated antibodies and antigens and their use in cancer diagnosis | |
| ATE343596T1 (de) | Humane monoklonale antikörper gegen inselzellantigen ia-2 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |